Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons
Intraoperative radiotherapy with electrons (ELIOT) after conservative surgery for breast carcinoma was introduced at the IEO in 1999 as a research programme. The results on 1,822 patients treated from January 2000 to December 2008 are reported. Women with unicentric primary breast carcinoma of less than 2.5 cm in the largest diameter were assessed by imaging. All patients were treated with breast-conserving surgery (quadrantectomy). ELIOT was delivered by two mobile linear accelerators immediately after breast resection with a single dose of 21 Gy. Local side effects of ELIOT were mainly liponecrosis (4.2%) and fibrosis (1.8%). After a mean follow-up of 36.1 months, 42 women (2.3%) developed a local recurrence, 24 (1.3%) a new primary ipsilateral carcinomas and 26 (1.4%) distant metastases as first event. Forty-six women died (2.5%), 28 for breast carcinoma and 18 for other causes. Five- and ten-year survivals were, respectively, 97.4 and 89.7%. ELIOT appears a promising feature in early breast cancer treated with breast conserving surgery, reducing the exposure of normal tissues to radiations and shortening the radiation course from 6 weeks to one single session.
KeywordsBreast cancer Intraoperative radiotherapy Conserving surgery
We thank the American-Italian Cancer Foundation, New York, Jacqueline Seroussi Foundation, Tel Aviv for financial support, William Russell-Edu for help with the English revision, and Maria Grazia Villardita for her constant help in the preparation of the manuscript.
- 19.Rosen PP, Oberman HA (1993) Tumors of the mammary gland. In: Atlas of tumor pathology, 3rd ser., fasc. 7. Armed Forces Institute of Pathology, Washington, DC, pp 135–156Google Scholar
- 27.Reitsamer R, Peintinger F, Kopp M et al (2004) Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol 180:38–44CrossRefPubMedGoogle Scholar
- 34.Finsterer H (1915) Zur therapie inoperable magen—und Darmkarzinome mit freilegund und nachfolgender Rontgenbestrahlung. Strahlentherapie 6:205–213Google Scholar
- 37.Holmes DR, Baum M, Joseph D (2007) The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg 194:507–510CrossRefPubMedGoogle Scholar
- 38.Sindelar WF, Johnstone PA, Hoekstra H (1999) Normal tissue tolerance to IORT: The NCI experimental studies. In: Gunderson LL, Willett CG, Harrison LB et al (eds) Intraoperative irradiation: techniques and results. Humana Press, Totowa, pp 131–146Google Scholar